Sort
82,697 grants matching “vaccine development”
Western States Node of the National Drug Abuse Treatment Clinical Trials Network
$901,841James L. Sorensen · University Of California, San Francisco · UG1 · FY2017 · DA
Recombinant life attenuated vaccine against Argentine hemorrhagic fever
$901,836Slobodan Paessler · University Of Texas Med Br Galveston · R01 · FY2011 · AI
Immunotherapeutics Against Other Filovirus Threats
$901,735Jonathan R. Lai · Scripps Research Institute, The · U19 · FY2014 · AI
Design of native-like SOSIP trimers
$901,723John P Moore · Weill Medical Coll Of Cornell Univ · P01 · FY2019 · AI
Pacific Ovarian Cancer Research Consortium
$901,655Charles Drescher · Fred Hutchinson Cancer Research Center · P50 · FY2015 · CA
Marburg Vaccine Development
$901,608Nancy J Sullivan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Ebola Vaccine Development
$901,608Nancy J Sullivan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Preclinical Development of SB 44 as an Orally Bioavailable Anti-HBV Agent
$901,490Radhakrishnan P Iyer · Spring Bank Technologies, Inc. · R01 · FY2015 · AI
ADOLESCENT MEDICINE TRIALS UNIT
$901,485Donna Futterman · Albert Einstein College Of Medicine · U01 · FY2014 · HD
Development and Production of alphavirus vaccines
$901,428Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2016 · AI
Multicenter AIDS Cohort Study
$901,232Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · U01 · FY2009 · AI
Design and testing of germline-targeting and boosting immunogens to elicit 10E8-like broadly neutralizing antibodies against HIV
$901,223William R Schief · Scripps Research Institute, The · R01 · FY2023 · AI
Design and testing of germline-targeting and boosting immunogens to elicit 10E8-like broadly neutralizing antibodies against HIV
$901,223William R Schief · Scripps Research Institute, The · R01 · FY2022 · AI
Optimizing Humoral Responses to HIV-1 Env Vaccine Antigens
$901,125Garnett H Kelsoe · University Of Pennsylvania · P01 · FY2022 · AI
Immunogen design to elicit polyclonal bNAb responses to the V3 glycan supersite
$901,125Kevin Wiehe · University Of Pennsylvania · P01 · FY2022 · AI
Drug Repurposing Screening for Zika Virus Infection
$901,090Wei Zheng · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR
A single antiviral to treat multiple opportunistic infections
$901,086Stacy Remiszewski · Evrys Bio, Llc · R44 · FY2020 · AI
TASK C33:Development of a Non-Human Primate Model of Zika Virus Infection for Product Evaluation
$901,048Jonathan Rayner · Southern Research Institute · N01 · FY2016 · AI
Mucosal Vaccination Against Dengue Virus Infection
$901,017Sujan Shresta · La Jolla Institute For Immunology · U01 · FY2009 · AI
Endolysins as tools to eradicate pneumococcal biofilms and development of protective immunity
$901,010Norberto Gonzalez-Juarbe · J. Craig Venter Institute, Inc. · R01 · FY2023 · AI
VIRUS-LIKE PARTICLES WITH STABILIZED TRIMERIC ENVELOPE FOR PRIME BOOST IMMUNIZATION
$900,802Shiu-Lok Hu · University Of Washington · R01 · FY2020 · AI
Preclinical Evaluation of Novel Ad/MVA and Ad/Protein HIV-1 Vaccines
$900,515Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2014 · AI
Development of PSMA -based recombinant protein vaccines
$900,492Progenics Pharmaceuticals, Inc. · R44 · FY2005 · CA
The Electronic Medical Records and Genomics (eMERGE) Network Phase III - Coordinating Center (U01)
$900,400Josh F. Peterson · Vanderbilt University Medical Center · U01 · FY2020 · HG
CCR, LGI, Flow Cytometry Core Facility
$900,397Karen Wolcott · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA